Renal Denervation Rediscovered
Welcome to Expert Insights
Professor Markus Schlaich on the evolution of hypertension management
Circumferential ablation technology and new ESH guidelines¹ are driving a resurgence of renal denervation in Australia, creating a rapidly evolving landscape of hypertension management.
Expert Insights is your go-to resource for the latest developments.
Created specifically for Australian Interventional Cardiologists, Expert Insights helps you stay at the forefront of advancing patient care, by providing on-demand access to the key information you need.
Hear directly from thought leader Professor Schlaich on advancements in renal denervation technology, the latest research findings, and the implications of recent updates to the ESH guidelines¹ positioning renal denervation as the third pillar of hypertension management.
With his fresh perspectives and practical tips, Prof Schlaich’s expert insights will help you integrate the new developments into practice, and move forward with confidence.
Each talking point has been broken down into short videos so you can find what you need, fast.
Sham controlled trials inform proof-of-concept
Leading expert Professor Markus Schlaich on how renal denervation proof-of-concept has been positively demonstrated by sham controlled trials.
Want more insights from leading proceduralists?
In an Australian first, The Renal Denervation Virtual Cath Lab gives you unprecedented access to a range of cases. Complete with real-time monitoring data, 360° views and procedural narration, we bring the cath lab direct to you.
Circumferential technology: enhanced outcomes*
Prof Schlaich describes how circumferential ablation technology has critically improved efficacy since the first renal denervation procedure in 2007.
*compared to first generation single-electrode RF-RDN technology
Real-world registry captures global data
Discover the role the Global Symplicity™ Registry has played in testing efficacy and durability of renal denervation across multiple patient segments, including high-risk cohorts.
Evidence supports renal safety profile
Despite initial concerns that renal denervation would adversely impact kidney function, Prof Schlaich shares what 15 years of safety data have revealed.
Watch expert Australian interventional cardiologist Professor Sanjay Patel perform renal denervation procedures in The Virtual Cath Lab. Complete with real-time monitoring data, 360° views and narration by Prof Patel, there are many developments in renal denervation ready to discover.
1
Mancia G, Kreutz R, Brunström M et al. 2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023; 41:1874–2071